Literature DB >> 525439

Disopyramide plasma levels in cardiac patients on maintenance therapy.

K Landmark, L Storstein, A Larsen.   

Abstract

The antiarrhythmic agent disopyramide, in a dosage of 200 mg/8 h, was given to 7 cardiac patients. The drug was fairly rapidly absorbed, and the mean peak plasma concentration (3.5 microgram/ml) was measured 1 h after administration of the first dose. The mean biological half-life (7.8 h) was slightly prolonged compared to that reported in normal volunteer subjects. Mean steady state plasma concentrations within the therapeutic range were attained 24--32 h after the start of medication. The fluctuations in the plasma levels were in the order or 30 percent; however, a wide spread of the values was observed. The drug was well tolerated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525439     DOI: 10.1111/j.0954-6820.1979.tb13532.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

Review 1.  Clinical pharmacokinetics of disopyramide.

Authors:  A Karim; C Nissen; D L Azarnoff
Journal:  J Pharmacokinet Biopharm       Date:  1982-10

2.  Pharmacokinetics of disopyramide in patients with chronic renal failure.

Authors:  B Francois; R Mallein; J Rondelet; M Lussignol
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

3.  Plasma concentration of disopyramide given as capsules and controlled release tablets.

Authors:  K Arnman; C Graffner; L Rikner; L Ryden; L Voog
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure.

Authors:  K Landmark; J E Bredesen; E Thaulow; S Simonsen; J P Amlie
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.